Neurocrine Biosciences Inc., 10% Owner at Voyager Therapeutics, Inc. (VYGR), bought 8,791,176 shares at $8.88 ($78.1M) on 2023-02-23, disclosed to the SEC on 2023-02-24.
Open-market purchase of $78.1M VYGR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.88 | 4,395,588 | $39.0M | 50.0% |
| 2 | $8.88 | 4,395,588 | $39.0M | 50.0% |
| Total | $8.88 avg | 8,791,176 | $78.1M | 100% |